What's New

Biospecimen Tables

07/06/2021 – Primary Diagnosis and Second Malignancy

Recent CCSS Publications

  • Asdahl PH, Oeffinger KC, Albieri V, Hudson M, Leisenring WM, Donaldson S, Hasle H, Winther JF, Armstrong GT, Robison LL. Esophageal disease among childhood cancer survivors — a report from the Childhood Cancer Survivors Study. Pediatr Blood Cancer, 2021; Epub Apr 12, 2021.
  • Sim JA, Hyun G, Gibson TM, Yasui Y, Leisenring W, Hudson MM, Robison LL, Armstrong GT, Krull KR, Huang IC. Negligible effects of the survey modes for patient-reported outcomes: a report from the Childhood Cancer Survivor Study. JCO Clin Cancer Inform, 2020; 4:10-24.
  • Oeffinger KC, Stratton KL, Hudson MM, Leisenring WM, Henderson TO, Howell RM, Wolden SL, Constine LS, Diller LR, Sklar CA, Nathan PC, Castellino SM, Barnea D, Smith SA, Hutchinson RJ, Armstrong GT, Robison LL. Impact of risk-adapted therapy for pediatric Hodgkin Lymphoma on risk of long-term morbidity: a report from the Childhood Cancer Survivor Study. J Clin Oncol, 2021; Epub Feb 25. 2021.
  • Im C, Li N, Moon W, Liu Q, Morton LM, Leisenring WM, Howell RM, Chow EJ, Sklar CA, Wilson CL, Wang Z, Sapkota Y, Chemaitilly W, Ness KK, Hudson MM, Robison LL, Bhatia S, Armstrong GT, Yasui Y.  Genome-wide association studies reveal novel locus with sex-/therapy-specific fracture risk effects in childhood cancer survivors. J Bone Miner Res, 2021; 36(4):685-695.
  • Sapkota Y, Li N, Pierzynski J, Mulrooney DA, Ness KK, Morton LM, Michael JR, Zhang J, Bhatia S, Armstrong GT, Hudson MM, Robison LL, Yasui Y. Contribution of polygenic risk to hypertension among long-term survivors of childhood cancer. JACC CardioOncol, 2021, 3(1):76-84.

Latest results from long-term follow-up study